SLC5A2 and pulmonary vascular congestion: Mechanistically, SGLT2 inhibitors promote osmotic diuresis and natriuresis, reduce plasma volume and interstitial fluid, and improve diuretic efficiency, which together alleviate cardiac preload and pulmonary congestion.